ANTI-BLEMISH MATTE PRIMER

Product NDC: 69017-101
11-digit product format: 690170101
Labeler code: 69017
Product ID: 69017-101_b8bbedb2-be19-4c9a-a470-93422c8dbcda
Type: HUMAN OTC DRUG
Nonproprietary name: SALICLYLIC ACID
Dosage form: LOTION
Route: TOPICAL
Labeler: Jouer Cosmetics LLC
Application: part333D
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2014-01-01
Marketing end: 0000-00-00
Substance: SALICYLIC ACID
Active strength: 1 mg/100mL
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	69017-101		I	Inactivated by FDA	2026-10-05
excluded product	product	69017-101		I	Inactivated by FDA	2026-10-05
excluded package	package	69017-101	69017-101-03	I	Inactivated by FDA	2026-10-05
excluded package	package	69017-101	69017-101-02	I	Inactivated by FDA	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 88 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	69017-101-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	69017-101-03	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	69017-101-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	69017-101-03	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	69017-101-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	69017-101-03	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	69017-101-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	69017-101-03	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	69017-101-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	69017-101-03	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	69017-101-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	69017-101-03	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	69017-101-02	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	69017-101-03	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	69017-101-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	69017-101-03	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	69017-101-02	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	69017-101-03	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	69017-101-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	69017-101-03	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	69017-101-02	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	69017-101-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	69017-101-02	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	69017-101-03	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	69017-101-02	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	69017-101-03	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	69017-101-02	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	69017-101-03	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	69017-101-02	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	69017-101-03	`1332a3947898…`	`d4bfe170f9cd…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277	Product name	1	20190408

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
69017-101-02	2019-11-27	C162847	48780-1	9855e2a2-4faa-60a7-e053-dbdaa90a05bd	2026988d-7dfa-49ac-bd64-4c2bba197c39
69017-101-03	2019-11-27	C162847	48780-1	9855e2a2-48cc-60a7-e053-dbdaa90a05bd	fc5eff3e-a7fd-4207-9ef3-3f4e1645fbca

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
69017-101-01	ANTI-BLEMISH MATTE PRIMER	30 mL in 1 TUBE	LOTION	30	7
69017-101-02	ANTI-BLEMISH MATTE PRIMER	1 in 1 BOX	LOTION	1	7
69017-101-03	ANTI-BLEMISH MATTE PRIMER	1 mL in 1 PACKET	LOTION	1	2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
.ALPHA.-TOCOPHEROL ACETATE, DL-	INACTIVE INGREDIENT	WR1WPI7EW8	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
ALOE VERA LEAF	INACTIVE INGREDIENT	ZY81Z83H0X	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
ASIAN GINSENG	INACTIVE INGREDIENT	CUQ3A77YXI	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
BIOSACCHARIDE GUM-1	INACTIVE INGREDIENT	BB4PU4V09H	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED)	INACTIVE INGREDIENT	F68VH75CJC	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
CETYL ALCOHOL	INACTIVE INGREDIENT	936JST6JCN	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
ETHYLHEXYL PALMITATE	INACTIVE INGREDIENT	2865993309	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
ETHYLHEXYLGLYCERIN	INACTIVE INGREDIENT	147D247K3P	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
GINKGO	INACTIVE INGREDIENT	19FUJ2C58T	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
GLYCERYL STEARATE SE	INACTIVE INGREDIENT	FCZ5MH785I	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
HAMAMELIS VIRGINIANA LEAF WATER	INACTIVE INGREDIENT	8FP93ED6H2	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
OPUNTIA FICUS-INDICA STEM	INACTIVE INGREDIENT	MUD8892KHL	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
POLYOXYL 20 CETOSTEARYL ETHER	INACTIVE INGREDIENT	YRC528SWUY	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
STARCH, TAPIOCA	INACTIVE INGREDIENT	24SC3U704I	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
WATER	INACTIVE INGREDIENT	059QF0KO0R	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
.ALPHA.-TOCOPHEROL ACETATE, DL-	INACTIVE INGREDIENT	WR1WPI7EW8	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
ALOE VERA LEAF	INACTIVE INGREDIENT	ZY81Z83H0X	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
ASIAN GINSENG	INACTIVE INGREDIENT	CUQ3A77YXI	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
BIOSACCHARIDE GUM-1	INACTIVE INGREDIENT	BB4PU4V09H	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED)	INACTIVE INGREDIENT	F68VH75CJC	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
CETYL ALCOHOL	INACTIVE INGREDIENT	936JST6JCN	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
ETHYLHEXYL PALMITATE	INACTIVE INGREDIENT	2865993309	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
ETHYLHEXYLGLYCERIN	INACTIVE INGREDIENT	147D247K3P	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
GINKGO	INACTIVE INGREDIENT	19FUJ2C58T	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
GLYCERYL STEARATE SE	INACTIVE INGREDIENT	FCZ5MH785I	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
HAMAMELIS VIRGINIANA LEAF WATER	INACTIVE INGREDIENT	8FP93ED6H2	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
OPUNTIA FICUS-INDICA STEM	INACTIVE INGREDIENT	MUD8892KHL	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
POLYOXYL 20 CETOSTEARYL ETHER	INACTIVE INGREDIENT	YRC528SWUY	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
STARCH, TAPIOCA	INACTIVE INGREDIENT	24SC3U704I	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
69017-101	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	7	Legacy NDC, 2 package rows	20140621_2026988d-7dfa-49ac-bd64-4c2bba197c39.zip
69017-101	ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC]	2	Legacy NDC, 1 package rows	20140621_fc5eff3e-a7fd-4207-9ef3-3f4e1645fbca.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
O414PZ4LPZ	SALICYLIC ACID	69-72-7	SALICYLIC ACID

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
69017-101-01	69017010101	30 mL in 1 TUBE	30 ml	Historical
69017-101-02	69017010102	1 in 1 BOX		Historical
69017-101-03	69017010103	1 mL in 1 PACKET	1 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
ANTI-BLEMISH MATTE PRIMER - Jouer Cosmetics LLC	Jouer Cosmetics LLC	2014-06-21	HUMAN OTC DRUG LABEL	7
ANTI-BLEMISH MATTE PRIMER - Jouer Cosmetics LLC	Jouer Cosmetics LLC	2014-06-21	HUMAN OTC DRUG LABEL	2